{
    "nct_id": "NCT06545045",
    "official_title": "Pilot Testing of Metacognitive Strategy Training to Address Cancer-related Cognitive Impairment in Breast Cancer",
    "inclusion_criteria": "* self-reported CRCI (Global Rating of Cognition dysfunction as \"Moderately\" \"Strongly \"or \"Extremely\" AND a Cognitive Failures Questionnaire1 (CFQ) score >30)\n* completed treatment for active cancer diagnosis (invasive ductal or lobular BrCA Stages I, II, or III) at least 6 months but not greater than 3 years prior to participation\n* able to read, write, and speak English fluently\n* able to provide valid informed consent\n* have a life expectancy of greater than 6 months at time of enrollment\n* on stable doses (i.e., no changes in past 90 days) of medications that are known to impact cognitive function (i.e., anti-depressants)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 20 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* prior cancer diagnoses of other sites with evidence of active disease within the past year\n* active diagnoses of any acute or chronic brain-related neurological conditions that can alter normal brain anatomy or function (e.g., Parkinson's disease, dementia, cerebral infarcts) dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA)\n* severe depressive symptoms (Personal Health Questionnaire-9 (PHQ-9) score of â‰¥21)\n* history of severe traumatic brain injury, prolonged loss of consciousness (e.g., coma)\n* conditions contraindicated for MRI (e.g., electrical implants, pumps, claustrophobia)\n* blue-yellow colorblindness\n* pregnancy\n\nThe screening methods identified in parentheses next to appropriate inclusion/exclusion criteria will be used to verify appropriate selection of study participants.",
    "miscellaneous_criteria": ""
}